Anterix (ATEX)
(Delayed Data from NSDQ)
$40.03 USD
+0.37 (0.93%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $39.97 -0.06 (-0.15%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Price, Consensus and EPS Surprise
ATEX 40.03 +0.37(0.93%)
Will ATEX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ATEX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ATEX
Anterix (ATEX) Spectrum Powers Oncor's Private Wireless Network
Anterix (ATEX) Reports Q4 Loss, Lags Revenue Estimates
ATEX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Comtech Telecommunications (CMTL) Q3 Earnings Top Estimates
Wall Street Analysts Think Anterix (ATEX) Could Surge 64.49%: Read This Before Placing a Bet
Wall Street Analysts Believe Anterix (ATEX) Could Rally 48.88%: Here's is How to Trade
Other News for ATEX
Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference
Anterix Announces Board of Directors Nominees
Anterix Inc. (ATEX) Q4 2024 Earnings Call Transcript
Craig-Hallum Sticks to Their Buy Rating for Anterix (ATEX)
Anterix: A Balanced Hold Recommendation Amidst Positive Developments and Cautious Growth Prospects